Pneumoconioses & occupational lung disease (silicosis, asbestosis, coal workers' pneumoconiosis)
pneumoconioses-occupational · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Chronic fibrotic lung diseases from inhaled inorganic dusts: silicosis (quartz - mining, stone/engineered-stone cutting, sandblasting), asbestosis (asbestos), and coal workers' pneumoconiosis. There is no specific cure - management centres on exposure cessation, complication screening (TB, progressive massive fibrosis, lung cancer, mesothelioma), supportive care, and occupational/compensation processes. Highly relevant in India given silica and stone-industry exposure.
Red flags
- New or worsening symptoms (consider superimposed TB, lung cancer, or mesothelioma)
- Haemoptysis / weight loss
- Progressive massive fibrosis (large upper-zone conglomerate masses)
- Rapid progression (accelerated/acute silicosis from heavy engineered-stone exposure)
- Pleural effusion in asbestos-exposed (exclude mesothelioma)
- Right heart failure
Assessment
Differential diagnosis
- Idiopathic pulmonary fibrosis / other ILD
- Sarcoidosis
- Tuberculosis (and silicotuberculosis)
- Hypersensitivity pneumonitis
- Lung cancer / mesothelioma
- Chronic beryllium disease
- COPD/emphysema from the same exposures
Investigations
- Detailed OCCUPATIONAL and exposure history (job, dust type, duration, latency) - the diagnostic cornerstone
- CXR (ILO classification: upper-zone nodular opacities in silicosis/CWP; lower-zone reticulation + pleural plaques in asbestosis)
- HRCT thorax - better characterisation; identifies progressive massive fibrosis, plaques, early fibrosis
- Spirometry + DLCO (restrictive +/- obstructive; reduced gas transfer)
- ACTIVELY screen for TB - sputum AFB/culture + molecular test (silica greatly increases TB risk)
- Exclude/monitor malignancy: lung cancer (silica, asbestos) and mesothelioma (asbestos) - low threshold for CT in new symptoms
- Consider beryllium lymphocyte proliferation test if beryllium exposure
- Assess for cor pulmonale (echo) in advanced disease
Management
- Take a thorough occupational history and establish the dust/latency relationship
- REMOVE from further exposure - the single most important intervention to prevent progression
- Confirm pattern on CXR/HRCT and classify; exclude mimics (TB, sarcoid, IPF, malignancy)
- Screen for and treat tuberculosis - silicosis markedly raises TB risk (silicotuberculosis); have a low threshold and consider LTBI treatment
- Surveillance for complications: progressive massive fibrosis, lung cancer, mesothelioma (asbestos), cor pulmonale
- Supportive care: smoking cessation (multiplicative cancer risk with asbestos), vaccination (influenza/pneumococcal), pulmonary rehabilitation, oxygen if hypoxaemic
- Treat airflow limitation symptomatically (bronchodilators) and right heart failure as needed
- Advise on occupational compensation, workplace dust control, and notify per local occupational-disease regulations; refer advanced disease for transplant assessment
- Public-health angle: engineered/artificial stone (accelerated silicosis) is an emerging hazard needing workplace controls
Drugs & doses
No disease-specific drug therapy reverses the fibrosis - management is supportive and preventive
Anti-tuberculous therapy (2HRZE/4HR) if active TB; treat latent TB infection in silica-exposed per local policy [verify regimen]
Inhaled bronchodilators (LABA/LAMA) for coexisting airflow obstruction [verify product]
Supplemental oxygen (LTOT) if chronic hypoxaemia
Diuretics for cor pulmonale as indicated [verify dose]
Influenza/pneumococcal/COVID vaccination
Disposition
Outpatient respiratory/occupational-medicine management with complication surveillance. Notify occupational disease and support compensation claims. Admit for complications (TB, respiratory failure, suspected malignancy). Transplant referral in end-stage disease.
Complications & pitfalls
- Progressive massive fibrosis and respiratory failure
- Tuberculosis (silicotuberculosis) - markedly increased risk
- Lung cancer (silica and asbestos; synergistic with smoking) and mesothelioma (asbestos)
- Cor pulmonale
- Pneumothorax
- Autoimmune associations (silica: scleroderma, RA/Caplan syndrome, vasculitis)
Exam pearls
- There is no cure - stopping exposure is the key intervention; prevention via workplace dust control is paramount (occupational health).
- Silica dramatically increases TB risk - screen and maintain a low threshold for silicotuberculosis, and consider latent TB treatment.
- Asbestos + smoking multiply lung-cancer risk - aggressive smoking cessation is essential; asbestos also causes mesothelioma (pleural plaques are a marker of exposure, not themselves malignant).
- Engineered/artificial stone benchtop cutting causes accelerated silicosis in young workers - an emerging epidemic requiring exposure control (highly relevant in India).
- A careful occupational history, not a lab test, usually makes the diagnosis.
- Caplan syndrome = pneumoconiosis with rheumatoid nodules.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.